3D SYSTEMS CORP Segments Disclosure
| Year Ended December 31, | |||||||||||||||||
| (in thousands) | 2025 | 2024 | 2023 | ||||||||||||||
| Revenue: | |||||||||||||||||
| Healthcare Solutions | $ | 179,589 | $ | 189,736 | $ | 213,216 | |||||||||||
| Industrial Solutions | 207,313 | 250,385 | 274,853 | ||||||||||||||
Total revenue | 386,902 | 440,121 | 488,069 | ||||||||||||||
Cost of sales: | |||||||||||||||||
Healthcare Solutions | 107,783 | 116,237 | 128,066 | ||||||||||||||
Industrial Solutions | 148,074 | 159,706 | 163,582 | ||||||||||||||
Total cost of sales | 255,857 | 275,943 | 291,648 | ||||||||||||||
Gross profit: | |||||||||||||||||
Healthcare Solutions | 71,806 | 73,499 | 85,150 | ||||||||||||||
Industrial Solutions | 59,239 | 90,679 | 111,271 | ||||||||||||||
Total gross profit | 131,045 | 164,178 | 196,421 | ||||||||||||||
| Selling, general and administrative | (161,331) | (210,132) | (210,172) | ||||||||||||||
| Research and development | (65,037) | (86,479) | (89,466) | ||||||||||||||
Asset impairment charges | (760) | (144,967) | (302,787) | ||||||||||||||
Foreign exchange gain (loss), net | 3,637 | 2,452 | (4,825) | ||||||||||||||
Interest income | 3,956 | 7,302 | 19,511 | ||||||||||||||
Interest expense | (5,162) | (2,564) | (3,301) | ||||||||||||||
| Gain on disposition | 139,590 | — | — | ||||||||||||||
Other income, net | 3,654 | 20,214 | 32,307 | ||||||||||||||
Income (loss) before income taxes | $ | 49,592 | $ | (249,996) | $ | (362,312) | |||||||||||
| Year Ended December 31, | |||||||||||||||||
| (in thousands) | 2025 | 2024 | 2023 | ||||||||||||||
Depreciation and amortization: | |||||||||||||||||
Healthcare Solutions | $ | 5,431 | $ | 5,389 | $ | 4,593 | |||||||||||
Industrial Solutions | $ | 2,378 | $ | 2,947 | $ | 2,801 | |||||||||||
| Year Ended December 31, | |||||||||||||||||||||||
| (in thousands) | 2025 | 2024 | |||||||||||||||||||||
United States | $ | 68,893 | $ | 76,829 | |||||||||||||||||||
Belgium | 18,893 | 19,598 | |||||||||||||||||||||
Other foreign entities | 14,501 | 14,058 | |||||||||||||||||||||
| Total | $ | 102,287 | $ | 110,485 | |||||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 9, 2026 | Showing above |
| 2024 | Mar 27, 2025 | |
| 2023 | Aug 13, 2024 | |
| 2022 | Mar 16, 2023 | |
| 2021 | Mar 1, 2022 | |
| 2019 | Feb 26, 2020 | |
| 2018 | Feb 28, 2019 | |
| 2017 | Mar 14, 2018 | |
| 2016 | Feb 28, 2017 | |
| 2015 | Mar 14, 2016 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.